Updated Jul 16, 2026
Humphreys Keith has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Humphreys Keith is identified in SEC filings as a director of Indivior Pharmaceuticals, Inc. as of January 28, 2026. The available public context from the SEC filing provides no detailed professional background or prior roles beyond the board position. Name variants such as Keith Humphreys may appear in other documents. There is no death information available in the provided context.
| Role | Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 6.5K | $0.00 | |
| 2026-01-28 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 3.7K | $0.00 |
Humphreys Keith is identified in SEC filings as a director of Indivior Pharmaceuticals, Inc. as of January 28, 2026. The available public context from the SEC filing provides no detailed professional background or prior roles beyond the board position. Name variants such as Keith Humphreys may appear in other documents. There is no death information available in the provided co…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Humphreys Keith profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.